Search Results - Anna Bollinger
- Showing 1 - 6 results of 6
-
1
-
2
Analgesic therapy failure in a COMT HPS/HPS diplotype carrier heterozygous for the CYP2D6 *4 allele with fibromyalgia—a case report by Anna Bollinger, Julia Gianora, Tanja Schüpbach, Samuel S. Allemann, Céline K. Stäuble, Henriette E. Meyer zu Schwabedissen
Published in PAIN Reports (2025-04-01)Get full text
Article -
3
Impact and Enablers of Pharmacogenetic-Informed Treatment Decisions—A Longitudinal Mixed-Methods Study Exploring the Patient Perspective by Anna Bollinger, Melissa Semedo Fortes, Henriette E. Meyer zu Schwabedissen, Kurt E. Hersberger, Céline K. Stäuble, Samuel S. Allemann
Published in Pharmacy (2025-01-01)Get full text
Article -
4
Associations between (pharmaco-)genetic markers and postoperative pain after inguinal hernia repair – a prospective study protocol by Florine M. Wiss, Ulrich Dietz, Andreas Thalheimer, Sebastian Lamm, Robert Rosenberg, Samuel S. Allemann, Henriette E. Meyer zu Schwabedissen, Anna Bollinger, Markus L. Lampert
Published in BMC Medical Genomics (2024-12-01)Get full text
Article -
5
Association of Pharmacogenotyping and Patient-Reported Outcomes in Chronic Pain Management by Anna Bollinger, Kurt E. Hersberger, Julia Gianora, Isabelle O. Urdieux, Henriette E. Meyer zu Schwabedissen, Nikki Rommers, Matthias Schwenkglenks, Céline K. Stäuble, Samuel S. Allemann
Published in Health Services Insights (2025-07-01)Get full text
Article -
6
A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting by Céline K. Stäuble, Chiara Jeiziner, Anna Bollinger, Florine M. Wiss, Martin Hatzinger, Kurt E. Hersberger, Thomas Ihde, Markus L. Lampert, Thorsten Mikoteit, Henriette E. Meyer zu Schwabedissen, Samuel S. Allemann
Published in Pharmacy (2022-07-01)Get full text
Article